by Dee McLachlan
Israel’s population is nearly 8.8 million people with Zimbabwe being around 15 million. Israel has all the resources and wealth to pursue the most aggressive and expensive medical campaign to deal with the Corona Virus — and they have chosen mass vaccinations.
A The Times of Israel article, 25 March 2021, was entitled “With most Israelis now fully vaccinated, virus spread continues sharp drop-off”. The article suggests positive test rates have reached the lowest level since last June with only 470 new patients diagnosed Wednesday (24 March 2021). Since the start of the pandemic, 831,383 people have been diagnosed with the coronavirus and 6,165 people have died (as of 27/3/2021).
Ministry data also showed that 50.07% of the population have now received both doses of the Pfizer-BioNTech vaccine that Israel is using for its national COVID-19 inoculation program. And Health Minister Yuli Edelstein tweeted. “Due to them, Israel is beating the coronavirus. All that remains is to follow the instructions so that the coronavirus does not return.”
Medical News Today reported (in January) on the rollout of vaccines in Israel:
“As of January 19, 2021, 25.6% of the Israeli population have received their first vaccine dose, and 550,000 people have received both doses. To give some perspective, Israel is vaccinating residents at a rate of 32.4 people per 100, compared with 4.8 people per 100 in the U.S., and 7 per 100 in the United Kingdom.”
Meanwhile around the same time in Zimbabwe, on the 28th of January 2021, the government approved the use of Ivermectin. Why? An article entitled “Zimbabwe OKs use of Ivermectin after officials’ deaths” explains:
“This ministry’s decision comes a few days after the deaths of three cabinet ministers and several top government officials from COVID-19 in a short period of time.
“…It is in this regard, the authority is hereby granted for you to proceed to allow importation and use of these medicines [Ivermectin] under the supervision and guidance you outlined. Ivermectin can be evaluated for both treatment and prophylaxis,” the ministry said.”
Israel v Zimbabwe
Zimbabwe has to date recorded 36,805 COVID-19 cases, including 1,518 deaths. Israel with nearly half the population has about 4 times the number of deaths. What is dramatic is the sudden drop-off of deaths in Zimbabwe directly after the use of Ivermectin.
A comment here said “Case fatality rate is much lower in Israel, so not a very good endorsement of Ivermectin.” Not so. Israel has a very aggressive testing regime so any comparison between cases and mortality is meaningless. It’s the rate of decline that’s worthy of attention with regard to stratgey — i.e., vaccines v Ivermectin. That said, let us compare the rates and manner of decline.
The Patriot reported on 12 February 2021 that,
“The approval came after some doctors, who are at the forefront of fighting COVID-19, wrote to the Ministry of Health and Child Care seeking permission to use Ivermectin and Nanosilver to treat the scourge.”
What is astounding is that Australia has banned the use — a drug, Ivermectin, that has been in use around the world for over 40 years (for treatment of head lice, scabies, river blindness (onchocerciasis), strongyloidiasis, trichuriasis, ascariasis and lymphatic filariasis). It has been included on the WHO List of Essential Medicines and it has been proven safe – also in children. About 3.7 billion doses have been administered to humans, with virtually no recorded severe side-effects. To continue with the Patriot article:
“…Dr Martin Gill, an ear, nose and throat (ENT) specialist based in SA said Ivermectin is the most significant, safe and cost-effective drug for treatment in all phases of COVID-19 infections.
“This is the only medication that is effective as a prophylactic drug and a treatment in all stages of the disease. It has also been shown to be an effective treatment in the later stages of the disease to settle down the inflammatory process in the long haulers… Ivermectin controls and inhibits viral replication in the early stages of the disease and reduces the severity of the disease in the later, infective stages.
“In the final phase of the disease, the use of Ivermectin can reduce mortality rates by as much as 30 percent…”